Ftse Mib
37.055,70
-0,18%
DAX
21.787,00
-0,58%
S&P 500
6.025,99
-0,95%
NASDAQ
19.523,40
-1,36%
Bitcoin
96.417,28
-0,13%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Natera Inc (NTRA) Natera Inc (NTRA) Notizie

NTRA

Natera (NTRA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NTRA
DataOraFonteTitoloSimboloCompagnia
08/02/202503:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NTRANatera Inc
03/02/202522:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NTRANatera Inc
03/02/202513:00Business WireNatera Announces National Commercial Coverage for its Fetal RhD NIPTNASDAQ:NTRANatera Inc
25/01/202516:05Business WireNatera Announces Successful Readout of Randomized, Phase III CALGB (Alliance) / SWOG 80702 Clinical Trial in Colorectal CancerNASDAQ:NTRANatera Inc
22/01/202500:05Business WireNatera to Present New Data at the 2025 ASCO GI SymposiumNASDAQ:NTRANatera Inc
17/01/202515:00Business WireNatera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the YearNASDAQ:NTRANatera Inc
15/01/202513:00Business WireNatera Announces Innovation Roadmap, with Advancements in MRD and Early Cancer DetectionNASDAQ:NTRANatera Inc
13/01/202513:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NTRANatera Inc
13/01/202501:20Business WireNatera Announces Preliminary Fourth Quarter and Full-Year Results for 2024NASDAQ:NTRANatera Inc
07/01/202515:00Business WireNatera to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:NTRANatera Inc
17/12/202414:00Business WireCourt Grants Natera’s Request to Include Additional Patent in its Lawsuit Against NeoGenomicsNASDAQ:NTRANatera Inc
12/12/202414:00Business WireNatera Announces Enrollment of First Patients in SAGITTARIUS: a Randomized, Phase III Clinical Trial in Colon CancerNASDAQ:NTRANatera Inc
09/12/202414:00Business WireNatera and MyOme Announce Launch of iPRS™ for Breast Cancer Risk AssessmentNASDAQ:NTRANatera Inc
02/12/202414:00Business WireClinical Validation Study on Natera’s Fetal RhD NIPT Published in Obstetrics & GynecologyNASDAQ:NTRANatera Inc
27/11/202415:00Business WireNatera Announces Medicare Coverage for Prospera™ in Single Lung Transplant RecipientsNASDAQ:NTRANatera Inc
26/11/202401:57Business WireNatera to Present New SignateraTM Data in Multiple Abstracts at the San Antonio Breast Cancer SymposiumNASDAQ:NTRANatera Inc
25/11/202423:09PR Newswire (US)Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal™NASDAQ:NTRANatera Inc
25/11/202421:51Business WireNatera Issues Statement on Guardant Health LitigationNASDAQ:NTRANatera Inc
25/11/202415:00Business WireNatera Co-Founder and Executive Chairman Matthew Rabinowitz Named 2024 R&D Leader of the YearNASDAQ:NTRANatera Inc
21/11/202423:31Business WireNatera Announces Publication of over 100 Peer-Reviewed Papers on SignateraTMNASDAQ:NTRANatera Inc
12/11/202422:23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NTRANatera Inc
12/11/202422:05Business WireNatera Reports Third Quarter 2024 Financial ResultsNASDAQ:NTRANatera Inc
12/11/202413:00Business WireNatera Announces Completion of Signatera™ Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal CancerNASDAQ:NTRANatera Inc
08/11/202415:00Business WireNatera to Participate in Upcoming Investor ConferencesNASDAQ:NTRANatera Inc
01/11/202414:00Business WireNatera to Report its Third Quarter 2024 Results on November 12, 2024NASDAQ:NTRANatera Inc
23/10/202400:06Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:NTRANatera Inc
22/10/202415:00Business WireNatera to Present New Renasight Data at ASN Kidney Week 2024NASDAQ:NTRANatera Inc
23/09/202422:06Business WireCourt Orders Permanent Injunction Against NeoGenomics' Accused RaDaR Assay, as Case Enters New PhaseNASDAQ:NTRANatera Inc
16/09/202411:17Business Wire Natera Announces Three New Signatera Publications; Includes Groundbreaking Overall Survival Data Published in Nature Medicine and also Released at ESMONASDAQ:NTRANatera Inc
14/09/202420:16Business WireFirst of its Kind Colorectal Cancer Data from Prospective GALAXY Study Released at ESMO; Demonstrates Signatera's Ability to Predict Overall SurvivalNASDAQ:NTRANatera Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NTRA

La tua Cronologia

BIT
BPE
Bper Banca
BIT
IVG
Iveco Group NV
BIT
UCG
Unicredit
BIT
TIT
Telecom Italia
BIT
STLAM
Stellantis NV
BIT
ISP
Intesa Sanpaolo
BIT
BPSO
Banca Popolare di Sondrio
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
RACE
Ferrari NV
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
NEXI
Nexi S.p.A
BIT
STMMI
ST Microelectronics
BIT
FBK
Finecobank
BIT
LDO
Leonardo
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci